LX1001, a serotype rh.10 AAV gene transfer vector expressing the cDNA coding for human APOE2 is used in a phase 1/2 clinical trial in individuals with APOE4 homozygote AD (NCT03634007). This evidence concerns the gene APOE and Alzheimer disease.